Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus reuteri LM1063

Lactobacillus reuteri LM1063 · Lactomason Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactobacillus reuteri LM1063, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Effect of L. Reuteri LM1063 on Sleep Health Improvement [NA]

See pricing